Abstract
The goal of the project is to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures. National Cancer Institute (NCI) utilized whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing. The samples were processed and submitted for genomic characterization using pipelines and procedures established within The Cancer Genome Analysis (TCGA) project.
Catalogue metadata
- Record ID
- AISLI-R-0E038C72630710641130
- Type
- Datos
- Source catalogue
- registry.opendata.aws
- Tema
- 生命科学与生物医学
- Condiciones de uso
- NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies